Review articleAssessment of snakebite burdens, clinical features of envenomation, and strategies to improve snakebite management in Vietnam
Introduction
Snakebite is a calamity, particularly in the rural areas of tropical and sub-tropical countries, where the access to healthcare facilities is very limited. The World Health Organization (WHO) has declared snakebite a category A neglected tropical disease; galvanized by the sheer dearth of attention accorded to this deadly tropical disease (Chippaux, 2017). Globally, the highest incidence of snake bite is reported from Asia, with the South-east Asian countries being major contributors (Chippaux, 1998; Kasturiratne et al., 2008).
Vietnam in South-East Asia, with a land cover of 3, 10,000 km2 and a population of 92 million, is a large repository of varied herpetofauna. Of the approximately 140 species of snakes found in Vietnam; 31 species are venomous, of which 18 species are terrestrial and 13 species are marine (Harding and Welch, 1980; Quyen, 2003). Reports of snakebite incidence date from the Vietnam War in 1950 and underscore the heightened fear and mortality it caused among the soldiers (Berlinger and Flowers, 1973; Guillemot, 2009). The medically important venomous snakes of Vietnam, responsible for fatal bites in this region are shown in Table 1. It is noteworthy that, snakebite burden in other south-east Asian countries like Thailand (Chanhome et al., 1998; Pochanugool et al., 1998; Viravan et al., 1992), Malaysia (Chew et al., 2011; Jamaiah et al., 2006),and Myanmar (Chippaux, 1998; Mahmood et al., 2018; Pe et al., 2006) are well documented. However, snakebite incidences in Vietnam are neither globally or nationally comprehensively surveyed (Quyen, 2003). Only a few hospital-based data on snakebite in Vietnam are readily available (Blessmann et al., 2018; Eriksson, 2011; Eriksson and Nguyen, 2017; Quyen, 2003; Thang et al., 2020). The exact magnitude of the public-health calamity posed by snakebites in Vietnam is yet to be determined, which makes it difficult for public-health officials and policy makers to set up an appropriate framework for prevention and control of snakebite.
In this article, we have presented a comprehensive review and critical analysis of the burden and clinical features of snakebite, geographical variation of venom composition of medically important snakes, availability of antivenom, and management of snakebite in Vietnam by sifting through the literature available in public databases (Scopus, web of science, Pubmed, google scholar) covering the period from 1954 to 2020. We have also used the google search engine by employing key words; ‘snakebite in Vietnam’, ‘clinical report of snakebite in Vietnam’, 'snake venom characterization from Vietnam’ ‘epidemiological study of snakebite in Vietnam’; the search included sources in both English and Vietnamese.
Section snippets
Epidemiology of snakebite in Vietnam
Vietnam bears witness to approximately 30,000 snakebites annually with a mortality rate of 80 per million per year (Cheng and Winkel, 2001; Warrell, 1999). The first systematic reporting of snakebite in Vietnam was done by Swaroop and Grab in 1954 (Swaroop and Grab, 1954). Thereafter, only a few publications in English described the medically important snakes and snakebite burden in Vietnam. In the last decade, some community-based surveys and case studies on snakebite were done in different
Clinical features of snakebites in Vietnam
Understating of pathophysiology and clinical symptoms of envenomation are crucial factors in better management of snakebite (Mukherjee et al., 2020). Since commercial venom detection kits are not available in South Asian countries, clinicians rely on their experience, and the clinical manifestations of envenomed victims, for species identification and gauging the severity of envenomation (Mukherjee et al., 2020). Detailed studies on clinical features of snakebite in Vietnam are lacking and/or
Biochemical and proteomic analyses to decipher the venom composition of medically important snakes of Vietnam
Snake venom toxicity and lethality are exclusively dependent on their constituent enzymatic and non-enzymatic proteins and polypeptides. The determination of snake venom composition by conventional biochemical analyses in the 20th and early 21st centuries have proved insufficient to identify the non-enzymatic proteins and low abundance proteins in the venom (Kalita and Mukherjee, 2019). Identification as well as quantitation of non-enzymatic proteins in venom is cardinal to their vital role in
Clinical management of snakebite in Vietnam: the key issues
Although antivenom is the only approved treatment by WHO against snake envenomation; however, people of Vietnam mostly rely on the traditional healers, due to unavailability of antivenom in hospitals, high cost of antivenom treatment, and/or lack of social awareness (Eriksson, 2011; Eriksson and Nguyen, 2017). The standard protocol for snakebite treatment begins with identification of snake species. Due to lack of commercial diagnostic kits (Puzari and Mukherjee, 2020), the identification of
The proposed blue prints for augmenting therapy and clinical research on snakebite in Vietnam
A framework should be planned for better management of snakebite by improving the clinical research on snake bite, antivenom therapy and region-wise analysis of snake venom composition in Vietnam. A schematic diagram is shown in Fig.2 describes some of the important approaches to improve the snakebite management in Vietnam.
Conclusion and recommendations
Snakebite is a severe problem in Vietnam, yet measures to eradicate this NTD are rendered conspicuous by their absence. Epidemiological study of snakebite in Vietnam is inadequate and more studies are warranted to prepare a roadmap to improve snakebite management. Region-wise identification of medically important snakes and rapid identification of snakes responsible for bites are crucial for early and prompt treatment, and development of region-specific antivenom can definitely reduce the
Declaration of Competing Interest
The authors declare that there are no conflicts of interest in this study
Acknowledgements
AP received Senior Research Fellowships from DST-SERB, AISTDF. The study received grant from DST-SERB, AISTDF New Delhi project to AKM (IMRC/AISTDF/R&D/P-3/2017).
References (122)
- et al.
Sodium oleate, arachidonate, and linoleate enhance fibrinogenolysis by Russell's viper venom proteinases and inhibit FXIIIa; a role for phospholipase A2 in venom induced consumption coagulopathy
Toxicon
(2020) - et al.
Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom
Toxicon
(2017) - et al.
Incidence of snakebites in 3 different geographic regions in Thua Thien Hue province, central Vietnam: Green pit vipers and cobras cause the majority of bites
Toxicon
(2018) - et al.
Venoms, venomics, antivenomics
FEBS Lett
(2009) - et al.
Causes and consequences of snake venom variation
Trends Pharmacol. Sci.
(2020) - et al.
Quantitative proteomics to reveal the composition of Southern India spectacled cobra (Naja naja) venom and its immunological cross-reactivity towards commercial antivenom
Int. J. Biol. Macromol.
(2020) - et al.
Functional proteomic approach to discover geographic variations of king cobra venoms from Southeast Asia and China
J. Proteomics
(2013) - et al.
DNA aptamers against Taiwan banded krait α-bungarotoxin recognize Taiwan cobra cardiotoxins
Toxins
(2016) - et al.
A novel format for a rapid sandwich EIA and its application to the identification of snake venoms
J. Immunol. Methods
(1992) - et al.
Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital
J. Young Pharmacists
(2013)
Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection
J. Immunol. Methods
Medicinal plants used to treat snakebite in Central America: Review and assessment of scientific evidence
J. Ethnopharmacol.
Successful treatment of neurotoxic king cobra envenomation in Myrtle Beach, South Carolina
Ann. Emerg. Med.
Antivenoms for the treatment of snakebite envenomings: the road ahead
Biologicals
Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming
J. Proteomics
Toxins and drug discovery
Toxicon
Physicochemical characterization of commercial freeze-dried snake antivenoms
Toxicon
Comparative venom proteomics of banded krait (Bungarus fasciatus) from five geographical locales: Correlation of venom lethality, immunoreactivity and antivenom neutralization
Acta Tropica
Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators
Toxicon
Quantitative proteomic analysis and antivenom study revealing that neurotoxic phospholipase A 2 enzymes, the major toxin class of Russell's viper venom from southern India, shows the least immuno-recognition and neutralization by commercial polyvalent antivenom
Int. J. Biol. Macromol.
Proteome and immunome of the venom of the Thai cobra Naja kaouthia
Toxicon
Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin
J. Proteomics
Biochemical and biological activities of the venom of a new species of pitviper from Vietnam, Triceratolepidophis sieversorum.
Toxicon
Species-specific and geographical variation in venom composition of two major cobras in Indian subcontinent: Impact on polyvalent antivenom therapy
Toxicon
Dry bite” in venomous snakes: A review
Toxicon
Clinical Features, Bacteriology, and Antibiotic Treatment Among Patients with Presumed Naja Bites in Vietnam
Wilderness Environ. Med.
Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F (ab′) 2] antivenoms, in Bothrops asper bites in Colombia
Toxicon
A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms
Toxicon
Assessment of quality, safety, and pre-clinical toxicity of an equine polyvalent anti-snake venom (Pan Africa): Determination of immunological cross-reactivity of antivenom against venom samples of Elapidae and Viperidae snakes of Africa
Toxicon
Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib
Blood
Recent developments in diagnostic tools and bioanalytical methods for analysis of snake venom: A critical review
Anal. Chim. Acta
Proteomic characterization and comparison of Malaysian Bungarus candidus and Bungarus fasciatus venoms
J. Proteomics
The molecular basis of cross-reactivity in the Australian Snake Venom Detection Kit (SVDK)
Toxicon
Geographical variations in king cobra (Ophiophagus hannah) venom from Thailand, Malaysia, Indonesia and China: On venom lethality, antivenom immunoreactivity and in vivo neutralization
Acta Trop
Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia
Journal of proteomics
Functional venomics of the Sri Lankan Russell's viper (Daboia russelii) and its toxinological correlations
J. Proteomics
Integration of traditional and western medicine in Vietnamese populations: a review of health perceptions and therapies
Nat. Prod. Commun.
A decoy-receptor approach using nicotinic acetylcholine receptor mimics reveals their potential as novel therapeutics against neurotoxic snakebite
Front. Pharmacol.
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
Nat. Commun.
Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
PLOS Negl. Trop. Dis.
Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh
J. Venom. Anim. Toxins incl. Trop. Dis.
Novel Bradykinin-Potentiating Peptides and Three-Finger Toxins from Viper Venom: Combined NGS Venom Gland Transcriptomics and Quantitative Venom Proteomics of the Azemiops feae Viper
Biomedicines
Some Observations on the Treatment of Snakebites in Vietnam
Mil. Med.
Purification and characterization of a new cystatin inhibitor from Taiwan cobra (Naja naja atra) venom
Biochem. J.
Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis
Front. Ecol. Evol.
Mass spectrometric analysis to unravel the venom proteome composition of Indian snakes: opening new avenues in clinical research
Expert Rev. Proteomics
Venomous snakebite in Thailand I: medically important snakes
Mil. Med.
Snakebite and antivenoms in the Asia-Pacific: wokabaut wantaim, raka hebou (" walking together")
Med. J. Aust.
A five-year retrospective review of snakebite patients admitted to a tertiary university hospital in Malaysia
Int. J. Emerg. Med.
Snakebite envenomation turns again into a neglected tropical disease!
J. Venom. Anim. Toxins Incl. Trop. Dis.
Cited by (0)
- #
On deputation from Tezpur Universtiy, India